Audrey Greenberg

Audrey Greenberg turns moonshot ideas into market-shaping companies, and builds the teams, capital, and strategy to scale them. She is an award-winning biotech executive and company builder with a proven track record of scaling businesses at the intersection of science, capital, and impact. Audrey specializes in launching high-growth startups through capital formation, strategic partnerships, differentiated positioning, and top-tier team development. Her portfolio includes several multi-billion-dollar companies, and her experience spans C-suite roles across strategy, finance, operations, and commercialization. Audrey currently serves as a Mayo Venture Partner where she leads enterprise-wide efforts in venture creation, strategic capital markets, institutional spinouts, and the commercialization of transformative science and care delivery models. She works across the Mayo ecosystem to build and scale the next generation of healthcare companies - from therapeutics and diagnostics to enabling platforms and digital health. She serves on multiple boards and is active in industry organizations focused on women’s leadership, healthcare innovation, and public-private collaboration. Previously, Audrey was Global Head of SK pharmteco and Founder of the Center for Breakthrough Medicines (CBM), where she raised over $500 million and led the company through its acquisition by SK Group.